Health & Biotech
EZZ now has green light to sell Kourtney Kardashian’s favourite anti-ageing supplement in China
Health & Biotech
Dr Boreham’s Crucible: With new blood at the top, can CSL continue its reign?
Health & Biotech
ScoPo’s Powerplays: ASX health stocks drop 0.3% but reporting season gives cause for optimism
Health & Biotech
Unicorns Podcast: EZZ Life Science Holdings – the hidden gem of the ASX
Health & Biotech
Dimerix awarded $2.8 million R&D tax incentive claim to advance ACTION3 Phase 3 trial
Health & Biotech
ASX Health Stocks: CleanSpace and Sonic Healthcare leap double digits today on US, trial wins
Health & Biotech
Wellnex Life completes first delivery of Pharmacy Own products to leading pharmacy distributor CH2
Health & Biotech
ASX Health Stocks: Clarity Pharma shows effectiveness in diagnosing prostate lesions in Phase 1 trial
Health & Biotech
ASX Health Stocks: Emyria surges another 10pc; cannabis play Vitura delivers record profit
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall but cap raises show money flowing into sector
Health & Biotech
PharmAust reports extension of survival time and quality of life from MPL trial for dogs with B-cell lymphoma
Health & Biotech
CardieX Raises $4.5 million as it gears up for dual US listing as CONNEQT Pulse awaits FDA Clearance
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.